ASAM Drug Testing Pocket Guide

Drug Testing Pocket Guide

ASAM Opioid Addiction Treatment GUIDELINES Apps and Pocket Guides brought to you courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/840070

Contents of this Issue

Navigation

Page 35 of 35

Disclaimer is document attempts to define principles of practice that should produce high-quality patient care. It is applicable to specialists, primary care, and providers at all levels. is document should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. e ultimate judgment concerning the propriety of any course of conduct must be made by the clinician aer consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors endorse any product or service associated with the distributor of this clinical reference tool. Abbreviations 6-MAM, 6-monoacetylmorphine; AAP, American Academy of Pediatrics; ACOG, American Congress of Obstetricians and Gynecologists ; ASAM, American Society of Addiction Medicine; CLIA, Clinical Laboratory Improvement Amendments; EtOH, ethyl alcohol or ethanol; EtG, ethyl glucuronide; EtS, ethyl sulfate; MRO, Medical Review Officer; NIDA, National Institute on Drug Abuse; OBOT, office-based opioid treatment; OTP, opioid treatment program; OTS, opioid treatment services; PCP, phencyclidine; PHP, Physician Health Program; POCT, point of care testing ; RAM, RAND/UCLA Appropriateness Method; SAMHSA, Substance Abuse and Mental Health Services Administration; SBI, Screening and Brief Intervention; SBIRT, Screening, Brief Intervention, and Referral to Treatment; SUD, substance use disorder; UDT, urine drug testing Source Appropriate Use of Drug Testing in Clinical Addiction Medicine Available at: www.ASAM.org/DrugTesting 106 Commerce Street, Suite 105 Lake Mary, FL 32746 TEL: 407.878.7606 • FAX: 407.878.7611 Order additional copies at GuidelineCentral.com Copyright © 2017 All rights reserved ASAMDRU1763 Expert Panel Members Louis Baxter, MD, DFASAM; Lawrence Brown, MD, MPH, DFASAM; Matthew Hurford, MD, Expert Panel Moderator; William Jacobs, MD; Kurt Kleinschmidt, MD; Marla D. Kushner, DO, FACOFP, DFASAM, FSAHM; Lewis Nelson, MD; Michael Sprintz, DO, FASAM; Mishka Terplan, MD, MPH, FASAM; Elizabeth Warner, MD; Timothy Wiegand, MD, FACMT, FAACT, FASAM Resources 1 http://www.asam.org/docs/default-source/practice-support/quality-improvement/ asam-standards-of-care.pdf 2 http://www.asam.org/publications/the-asam-criteria 3 ASAM.GuidelineCentral.com for Calculators

Articles in this issue

Links on this page

Archives of this issue

view archives of ASAM Drug Testing Pocket Guide - Drug Testing Pocket Guide